News brief
On 2026-08-31, according to Xiniu Data, Yiyuan Biotechnology completed equity financing for an undisclosed amount. Investors were Kunshantianshi Phase Two Investment Fund Partnership (Limited Partnership). The company is a developer of embodied intelligent medical devices.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年8月31日，据烯牛数据报道，翌远生物完成股权投资融资，金额未披露。投资方为昆山天使二期投资基金合伙企业（有限合伙）。该公司为具身智能医疗器械研发商。